30 results
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
IDSA - Prophylaxis ... Opportunistic Disease in HIV-AIDS ... Papillomavirus (HPV ... #OIs #HIVAIDS #IDSA ... #management #pharmacology
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
IDSA - Prophylaxis ... Opportunistic Disease in HIV-AIDS ... Papillomavirus (HPV ... #OIs #HIVAIDS #IDSA ... #management #pharmacology
IDSA Recommendations for empirical antimicrobial therapy for purulent meningitis based on patient age and specific predisposing
IDSA Recommendations ... condition #IDSA ... Empiric #Coverage #InfectiousDiseases ... #Pharmacology # ... Management
IDSA Recommendations for Preventing Human Papillomavirus Infections and Cervical Cancer Screening for Women with in HIV-AIDS
Recommendations
IDSA Recommendations ... Women with in HIV-AIDS ... HumanPapillomavirus #IDSA ... Prevention #Treatment #management ... infections #HIVAIDS #pharmacology
Recommendations for specific antimicrobial therapy in bacterial meningitis based on isolated pathogen and susceptibility testing.

#IDSA #Meningitis
#IDSA #Meningitis ... Pathogens #Isolated #InfectiousDiseases ... #Pharmacology # ... Management
Here is a quick guide on the common direct-acting antivirals (DAAs) for chronic hepatitis C virus
hepatitis C virus (HCV ... table #treatment #hcv ... #medications #infectiousdisease ... HepC #HepatitisC #Management ... #Pharmacology
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
IDSA Recommendations ... Infections in HIV-AIDS ... Penicilliosis #IDSA ... Prevention #Treatment #management ... infections #HIVAIDS #pharmacology
Adjuvant therapies in critical care: steroids to treat infectious diseases
 - Severe Community Acquired Pneumonia
mechanical ventilation, ARDS ... Corticosteroids #Adjuvant #InfectiousDiseases ... #Infections #Pharmacology ... #Management #Treatment
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... Candidiasis in HIV-AIDS ... candida #mucosal #IDSA ... Prevention #Treatment #management ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS
Preventing Bacterial Enteric Illness:
 • Antimicrobial
IDSA Recommendations ... Infections in HIV-AIDS ... Enteric #Bacterial #IDSA ... Prevention #Treatment #management ... infections #HIVAIDS #pharmacology